Head to Head Analysis: Basel Medical Group (NASDAQ:BMGL) & SeaStar Medical (NASDAQ:ICU)

Basel Medical Group (NASDAQ:BMGL) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Insider & Institutional Ownership

1.7% of SeaStar Medical shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Basel Medical Group and SeaStar Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
SeaStar Medical	-984.60%	-188.47%	-106.42%

Valuation & Earnings

This table compares Basel Medical Group and SeaStar Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$8.90 million	1.31	-$9.50 million	N/A	N/A
SeaStar Medical	$1.23 million	13.75	-$12.15 million	($8.30)	-0.51

Basel Medical Group has higher revenue and earnings than SeaStar Medical.

Analyst Recommendations

This is a summary of current ratings and target prices for Basel Medical Group and SeaStar Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1	0	0	0	1.00
SeaStar Medical	1	0	0	0	1.00

SeaStar Medical has a consensus price target of $6.00, suggesting a potential upside of 41.51%. Given SeaStar Medical’s higher possible upside, analysts clearly believe SeaStar Medical is more favorable than Basel Medical Group.

Volatility & Risk

Basel Medical Group has a beta of -0.19, meaning that its stock price is 119% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.21, meaning that its stock price is 221% less volatile than the S&P 500.

Summary

Basel Medical Group beats SeaStar Medical on 6 of the 10 factors compared between the two stocks.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.